Objectives: To report insidious development of autonomic dysreflexia and hydronephrosis due to dyssynergic voiding following discontinuation of intrathecal baclofen therapy. Setting: Regional Spinal ...

Medcare Women & Children Hospital has successfully administered a pioneering intrathecal gene therapy for Spinal Muscular ...

The newly licensed intrathecal gene therapy expands life-changing treatment options for children and adults affected by ...

Please provide your email address to receive an email when new articles are posted on . Early intrathecal therapy effectively resolved symptoms related to high-grade neurotoxicity among patients who ...

Panelists discuss how emerging intrathecal gene therapy for older patients with spinal muscular atrophy (SMA) shows modest efficacy with fewer systemic adverse effects than intravenous administration, ...

Practitioners from around the country who have extensive experience in intrathecal baclofen (ITB) therapy gathered in early 2004 to develop best-practice guidelines for ITB therapy. Discussion focused ...

Intrathecal baclofen (ITB) therapy has evolved into a standard treatment for severe spasticity. After this therapy had been provided for 10 years, a retrospective chart review on 50 patients, ...

Vancouver, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The global market for Intrathecal Baclofen (ITB) therapy systems reached a value of USD 1.11 Billion in the year 2022. According to the most recent ...

Gene delivery into the spinal cord provides a potential approach to the treatment of spinal cord traumatic injury, amyotrophic lateral sclerosis, and spinal muscular atrophy. These disorders progress ...

Mallinckrodt plc has entered into an agreement to sell its Intrathecal Therapy business for approximately $203 million to Piramal Critical Care, the United Kingdom-based subsidiary of Piramal ...